Abstract:Due to the lack of comprehensive data on bilateral sudden sensorineural hearing loss (BSSHL) and its subtypes, we conducted a systematic review and meta‐analysis to better understand the characteristics and prognosis of BSSHL compared to unilateral sudden sensorineural hearing loss (USSHL). We found that BSSHL is considerably rarer and has poorer prognosis in comparison to USSHL. Furthermore, BSSHL, and simultaneous BSSHL in particular, has significantly greater associations with more systemic pathologies compared to USSHL, including hypertension, cardiovascular disease, and autoimmune disease. Objectives To comprehensively examine the characteristics and prognosis of bilateral sudden sensorineural hearing loss (BSSHL) and its subtypes compared to unilateral sudden sensorineural hearing loss (USSHL). Data Sources PubMed, Scopus, and CINAHL. Review Methods Databases were searched from inception to December 5, 2023, for studies reporting patient characteristics and audiometric outcomes for BSSHL and its simultaneous (Si‐BSSHL) and sequential (Se‐BSSHL) subtypes. Meta‐analysis of continuous measures, proportions (%), mean differences (Δ), and odds ratio (OR) were performed. Results Eleven studies were included, consisting of 368 patients with BSSHL and 2,705 patients with USSHL. The pooled prevalence among all SSHL cases was 88.1% (95% CI: 81.2%–93.6%) for USSHL and 11.9% (95% CI: 6.4% to 18.8%) for BSSHL. PTA improvement following treatment with steroids was significantly worse in patients with BSSHL (Δ15.3 dB; 95% CI: 14.6 to 15.9; p

Prognosis of Bilateral Sudden Sensorineural Hearing Loss: A Systematic Review and Meta‐Analysis